<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00765167</url>
  </required_header>
  <id_info>
    <org_study_id>ATO-2007-PLA-01-RR</org_study_id>
    <nct_id>NCT00765167</nct_id>
  </id_info>
  <brief_title>Training and Calibration of Dental Examiners</brief_title>
  <official_title>Training and Calibration of Dental Examiners</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Colgate Palmolive</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Colgate Palmolive</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Training and calibration of dental examiners&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2007</start_date>
  <completion_date type="Actual">December 2007</completion_date>
  <primary_completion_date type="Actual">December 2007</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Dental plaque</measure>
    <time_frame>6 weeks</time_frame>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">18</enrollment>
  <condition>Dental Plaque</condition>
  <arm_group>
    <arm_group_label>A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoride</intervention_name>
    <description>Brush half mouth twice daily for four days</description>
    <arm_group_label>A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Triclosan</intervention_name>
    <description>Brush half mouth daily for four days</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Chlorhexidine gluconate</intervention_name>
    <description>Mouth rinsing with 15 ml for 30 seconds twice a day for four days</description>
    <arm_group_label>C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Fluoride</intervention_name>
    <description>Brush half mouth daily for four days</description>
    <arm_group_label>B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Male or female volunteers 18-65 years of age&#xD;
&#xD;
          -  Good general health&#xD;
&#xD;
          -  Must sign informed consent form&#xD;
&#xD;
          -  Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.&#xD;
&#xD;
          -  No history of allergy to personal care consumer products, or their ingredients,&#xD;
             relevant to any ingredient in the test products as determined by the dental/medical&#xD;
             professional monitoring the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects unable or unwilling to sign the informed consent form.&#xD;
&#xD;
          2. Medical condition which requires pre-medication prior to dental visits/procedures&#xD;
&#xD;
          3. Moderate or advanced periodontal disease or heavy dental tartar (calculus).&#xD;
&#xD;
          4. 2 or more decayed untreated dental sites at screening.&#xD;
&#xD;
          5. Other disease of the hard or soft oral tissues.&#xD;
&#xD;
          6. Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).&#xD;
&#xD;
          7. Use of medications that can affect salivary flow (e.g. anticholinergics, adrenergics,&#xD;
             antihistamines, vasoconstrictors or decongestants).&#xD;
&#xD;
          8. Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.&#xD;
&#xD;
          9. Pregnant or nursing women.&#xD;
&#xD;
         10. Participation in any other clinical study within 1 week prior to enrollment into this&#xD;
             study.&#xD;
&#xD;
         11. Allergy to chlorhexidine&#xD;
&#xD;
         12. Use of tobacco products&#xD;
&#xD;
         13. Subjects who must receive dental treatment during the study dates.&#xD;
&#xD;
         14. Current use of Antibiotics for any purpose.&#xD;
&#xD;
         15. Presence of an orthodontic appliance.&#xD;
&#xD;
         16. History of allergy to common dentifrice ingredients.&#xD;
&#xD;
         17. Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Deasy, DDS</last_name>
    <role>Principal Investigator</role>
  </overall_official>
  <location>
    <facility>
      <name>UMDNJ Dental School</name>
      <address>
        <city>Newark</city>
        <state>New Jersey</state>
        <zip>07101</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2008</verification_date>
  <study_first_submitted>September 23, 2008</study_first_submitted>
  <study_first_submitted_qc>September 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 2, 2008</study_first_posted>
  <last_update_submitted>October 2, 2008</last_update_submitted>
  <last_update_submitted_qc>October 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 3, 2008</last_update_posted>
  <responsible_party>
    <name_title>William DeVizio/VP - Clinical Research</name_title>
    <organization>Colgate Palmolive</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dental Plaque</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chlorhexidine</mesh_term>
    <mesh_term>Chlorhexidine gluconate</mesh_term>
    <mesh_term>Triclosan</mesh_term>
    <mesh_term>Fluorides</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

